Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Portal Vein Tumor Invasion”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableLooking for participantsNCT05984511
What this trial is testing

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular CarcinomaHepatic Portal Vein Tumor InvasionTumor Thrombus
Third Affiliated Hospital, Sun Yat-Sen University 234
Not applicableStudy completedNCT04771988
What this trial is testing

Radioembolization for Hepatocellular Carcinoma With Portal Vein Tumoral Thrombosis

Who this might be right for
Hepatocellular Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 17
Large-scale testing (Phase 3)Active Not RecruitingNCT05198609
What this trial is testing

Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal Vein Invasion: a Randomized Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 214
Testing effectiveness (Phase 2)Ended earlyNCT01480817
What this trial is testing

Sorafenib VS TACE in HCC Patients With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital 2
Not applicableStudy completedNCT07075562
What this trial is testing

TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma (HCC)
The First Hospital of Hebei Medical University 180
Testing effectiveness (Phase 2)Study completedNCT00055692
What this trial is testing

Bevacizumab in Treating Patients With Unresectable Nonmetastatic Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaLocalized Unresectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
National Cancer Institute (NCI) 46
Not applicableEnded earlyNCT01690715
What this trial is testing

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery

Who this might be right for
Hepatocellular CarcinomaPortal Vein ThrombosisHepatic Portal Vein Tumor Invasion
Hospital Sirio-Libanes 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05908916
What this trial is testing

Atezolizumab and Bevacizumab With Combined Radiotherapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yonsei University 51
Testing effectiveness (Phase 2)Study completedNCT05625893
What this trial is testing

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Samsung Medical Center 63
Testing effectiveness (Phase 2)UnknownNCT03971201
What this trial is testing

Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion

Who this might be right for
Hepatocellular Cancer
White Plains Hospital 200
Testing effectiveness (Phase 2)UnknownNCT03261791
What this trial is testing

Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01850368
What this trial is testing

Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombus
Korea Cancer Center Hospital 35
Large-scale testing (Phase 3)WithdrawnNCT02149771
What this trial is testing

Combination Treatment for Advanced Liver Cancer

Who this might be right for
Hepatocellular CarcinomaHepatic Portal Vein Tumor Invasion
Shanghai Zhongshan Hospital
Post-approval studies (Phase 4)Study completedNCT01952353
What this trial is testing

Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion

Who this might be right for
Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Sun Yat-sen University 330
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Not applicableWithdrawnNCT01857726
What this trial is testing

Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion

Who this might be right for
Hepatocellular Carcinoma
Seoul National University Hospital
Large-scale testing (Phase 3)UnknownNCT04167293
What this trial is testing

Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)

Who this might be right for
Hepatocellular Carcinoma
Mian XI 116